Dermatologists weigh in: can a tiny dose of acne drug turn back the clock on aging skin?
NCT ID NCT07296536
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study asks a panel of 15 experienced dermatologists to share their opinions on using very low doses of isotretinoin (a drug usually used for acne) to improve skin texture, reduce pore size, and slow signs of aging. No patients receive treatment; instead, the goal is to create expert guidelines on who might benefit, how to dose the drug safely, and what monitoring is needed. The results will help doctors make informed decisions about this off-label use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOTRETINOIN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Venus Research Center
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Acne Drug's hidden toll on the eye revealed
- Peel vs laser: which skin fix wins?
- New radiofrequency gadget aims to lift faces without surgery
- Laser showdown: which device rejuvenates skin best?
- Beauty experts unite: new guidelines for safer skin treatments in MENA
- Top dermatologists unite to tame acne treatment chaos